Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas

Author: Stevenson J.P.   Scher R.M.   Kosierowski R.   Fox S.C.   Simmonds M.   Yao K.-S.   Green F.   Broom C.   Fields S.Z.   Krebs J.B.   O'Dwyer P.J.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.34, Iss.9, 1998-08, pp. : 1358-1362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content